Published in Mol Med on September 12, 2016
Distance in cancer gene expression from stem cells predicts patient survival. PLoS One (2017) 0.75
Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet (2000) 24.22
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res (2010) 10.97
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer (2011) 7.69
CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res (2010) 5.42
The role of CXC chemokines and their receptors in cancer. Cancer Lett (2008) 3.84
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res (2008) 3.32
Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res (2010) 3.18
Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn (2004) 3.13
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res (2003) 3.03
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer (2005) 2.84
The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl (2004) 2.65
Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (2009) 2.59
HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res (2007) 2.22
Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time. Clin Gastroenterol Hepatol (2012) 2.11
Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int J Cancer (1997) 2.08
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene (2003) 1.96
Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun (2009) 1.84
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis. Am J Gastroenterol (2015) 1.78
CXCR4 and cancer. Pathol Int (2010) 1.73
Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol Ther (2009) 1.65
The inflammatory microenvironment in colorectal neoplasia. PLoS One (2011) 1.62
CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer (2007) 1.62
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology (2012) 1.61
Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology (2011) 1.55
Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol (2007) 1.54
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer (2006) 1.48
Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One (2013) 1.41
Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int J Colorectal Dis (2010) 1.31
Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res (2010) 1.27
Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One (2012) 1.17
COMPARTMENTS: unification and visualization of protein subcellular localization evidence. Database (Oxford) (2014) 1.16
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer (2009) 1.16
Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol (2008) 1.15
Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. Am J Pathol (2004) 1.12
GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res (2006) 1.12
The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res (2012) 1.07
Coexpression of stemness factors Oct4 and Nanog predict liver resection. Ann Surg Oncol (2012) 1.06
Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma. Med Oncol (2011) 1.04
Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Cancer Res (2010) 1.03
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells. Blood Cancer J (2014) 1.02
Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin J Cancer (2013) 1.02
A key role for early growth response-1 and nuclear factor-kappaB in mediating and maintaining GRO/CXCR2 proliferative signaling in esophageal cancer. Mol Cancer Res (2009) 0.99
Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug. Med Oncol (2013) 0.97
Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells. PLoS One (2009) 0.96
Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases. Liver Int (2013) 0.96
Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma. Int J Gynecol Pathol (2011) 0.93
Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines. PLoS One (2013) 0.91
Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma. World J Gastroenterol (2011) 0.91
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming. Cell Cycle (2012) 0.91
Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells. J Cancer Res Clin Oncol (2012) 0.91
CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer. Oncol Lett (2011) 0.88
Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway. FEBS Lett (2014) 0.86
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Cancer Res (2007) 0.85
Low oxygen tension enhances hepatitis C virus replication. J Virol (2012) 0.84
Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med (2010) 0.83
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget (2015) 0.83
The role of pluripotency factors to drive stemness in gastrointestinal cancer. Stem Cell Res (2016) 0.80
Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients. Mol Diagn Ther (2015) 0.79
Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell. Front Physiol (2015) 0.79
Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. World J Gastroenterol (2006) 0.79
Hepatic differentiation of embryonic stem cells by murine fetal liver mesenchymal cells. Methods Mol Biol (2013) 0.78
Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection. PLoS One (2016) 0.78
Isolation, enumeration, and expansion of human mesenchymal stem cells in culture. Methods Mol Biol (2013) 0.78
A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma. Drug Des Devel Ther (2015) 0.77
Roles of sex-determining region Y-box 2 in cell pluripotency and tumor-related signaling pathways. Mol Clin Oncol (2015) 0.76
Overexpression of GRO-β is associated with an unfavorable outcome in colorectal cancer. Oncol Lett (2016) 0.76
Expression level of pluripotent genes in incomplete reprogramming. Asian Pac J Trop Med (2014) 0.76